Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.

Cape Breton musician was set to perform in Nova Scotia before a search summary incorrectly described him as a sex offender ...

When he returned solo for Season 10 as bosun, Nathan was already pining for Gael, as he made clear from the start. "There is, ...

‘Deadnaming’ Rachel Levine is not a small act. It’s a warning to the medical profession. We sometimes tell ourselves that ...

A biography of immediate past President, Muhammadu Buhari launched on Monday has revealed that the controversial naira ...

The Miami Marlins have more competition at first base after they re-acquired Brian Navarreto on a minor-league deal. Brian ...

A lawsuit between former Trump official Pete Marocco and a Florida design firm has gone on for over a decade, involving ...

With an AMD Ryzen AI Max 395, Radeon 8060S, and 128 GB RAM, the GMKtec EVO-X2 is equally ideal for local AI workflows and ...

Market is gaining momentum due to rising demand for biodegradable plastics, stringent regulations on single-use plastics, ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

As Ken Paxton campaigns for the U.S. Senate on conviction and faith, allegations of infidelity and a public divorce ...